Compare 10X Genomics Inc (TXG) vs Block Inc (XYZ) Price & Performance

TXG trades at $65.60, up 4.71% today, with a bullish technical signal and recent earnings beats. The stock shows improving fundamentals, with 2025 revenue at $642.82M and net loss narrowing to -$43.54M. Positive sentiment is driven by patent wins, Atera platform demand, and institutional interest, though valuation metrics like P/S of 13.58 and EV/EBITDA of 142.2 remain elevated.

Outlook is cautiously optimistic with upside potential from Atera execution, but risks include high valuation, persistent losses, and competitive pressures. Analyst consensus is mixed with a $50.56 price target below current levels, indicating near-term caution despite long-term growth prospects in genomics.

XYZ stock trades at $80.10, down 3.21% with a bearish technical signal. The company shows mixed fundamentals with strong revenue growth to $24.19B in 2025 but declining net income margins to 1.43%. Recent developments include expanding Cash App credit score access and applying for a national trust bank charter. Analyst consensus remains strongly bullish with 76% buy ratings and a $100.20 price target.

XYZ faces execution risks amid high P/E valuation of 143, though strategic initiatives in financial services provide growth catalysts. The stock offers 25% upside to consensus target but requires monitoring of profitability trends and regulatory approval for banking expansion.